Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
CALL
Lands' End
LE
$390M
| $328K | ﹤0.01% |
18,700
-2,000
| -10% | -$47.1K |
|
4527
CALL
Leggett & Platt
LEG
$1.32B
| $328K | ﹤0.01% |
7,500
-51,700
| -87% | -$2.32M |
|
4528
CALL
ProShares UltraPro Short S&P 500
SPXU
$378M
| $328K | ﹤0.01% |
102
-44
| -30% | -$153K |
|
4529
Stock Yards Bancorp
SYBT
$2.64B
| $328K | ﹤0.01% |
9,032
+6,395
| +243% | +$244K |
|
4530
CALL
iShares US Transportation ETF
IYT
$2.3B
| $327K | ﹤0.01% |
6,400
-10,800
| -63% | -$540K |
|
4531
CALL
Grand Canyon Education
LOPE
$3.79B
| $327K | ﹤0.01% |
2,900
+2,000
| +222% | +$233K |
|
4532
MasterCraft Boat Holdings
MCFT
$598M
| $327K | ﹤0.01% |
9,094
+3,830
| +73% | +$112K |
|
|
IIF
4533
Morgan Stanley India Investment Fund
IIF
$219M
| $326K | ﹤0.01% |
13,922
| – | – |
|
|
CHK
4534
CALL
DELISTED
Chesapeake Energy Corporation
CHK
| $326K | ﹤0.01% |
363
-617
| -63% | -$563K |
|
|
SGYP
4535
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $326K | ﹤0.01% |
191,487
-151,302
| -44% | -$271K |
|
4536
CALL
Idexx Laboratories
IDXX
$44.7B
| $325K | ﹤0.01% |
1,300
-21,100
| -94% | -$5.12M |
|
4537
PUT
Iron Mountain
IRM
$37.7B
| $325K | ﹤0.01% |
9,400
-7,700
| -45% | -$274K |
|
|
KG
4538
Kestrel Group
KG
$60.5M
| $325K | ﹤0.01% |
5,718
+3,378
| +144% | +$366K |
|
4539
Ocular Therapeutix
OCUL
$2.22B
| $325K | ﹤0.01% |
47,346
+23,254
| +97% | +$146K |
|
|
EPE
4540
DELISTED
EP Energy Corporation
EPE
| $325K | ﹤0.01% |
139,513
+76,559
| +122% | +$160K |
|
4541
Mercantile Bank Corp
MBWM
$1.06B
| $324K | ﹤0.01% |
9,729
+4,791
| +97% | +$171K |
|
4542
Daktronics
DAKT
$988M
| $323K | ﹤0.01% |
41,071
+26,987
| +192% | +$222K |
|
4543
Hackett Group
HCKT
$277M
| $323K | ﹤0.01% |
16,042
+6,683
| +71% | +$124K |
|
4544
Peoples Bancorp
PEBO
$1.49B
| $323K | ﹤0.01% |
9,252
+7,305
| +375% | +$268K |
|
|
TTSH
4545
DELISTED
Tile Shop Holdings
TTSH
| $323K | ﹤0.01% |
45,255
+32,175
| +246% | +$257K |
|
4546
Univest Financial
UVSP
$1.19B
| $323K | ﹤0.01% |
12,222
+7,753
| +173% | +$216K |
|
|
MIC
4547
CALL
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $323K | ﹤0.01% |
7,000
-45,500
| -87% | -$2.08M |
|
4548
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.75B
| $322K | ﹤0.01% |
+5,966
| New | +$320K |
|
|
NINE
4549
DELISTED
Nine Energy Service
NINE
| $322K | ﹤0.01% |
10,533
+9,447
| +870% | +$287K |
|
4550
PUT
Sunoco
SUN
$14B
| $322K | ﹤0.01% |
10,900
-200
| -2% | -$5.39K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.